GoodRx IPO Shows Low Drug Prices Can Still Mean Big Money

Shares of drug pricing company GoodRx soared on Wednesday, up 53% from its initial IPO list price of $33 at market close. The company best known for its drug discount coupons is also cashing in on the virtual care boom set off by the Covid-19 pandemic through its telemedicine services. The company started trading at $46 per share, $13 above its expected price, and  ended at $50.50 per share.The company’s market cap was $19.4 billion..